1. Home
  2. OGEN vs JZ Comparison

OGEN vs JZ Comparison

Compare OGEN & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • JZ
  • Stock Information
  • Founded
  • OGEN 1996
  • JZ 2011
  • Country
  • OGEN United States
  • JZ China
  • Employees
  • OGEN N/A
  • JZ N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • JZ Other Consumer Services
  • Sector
  • OGEN Health Care
  • JZ Real Estate
  • Exchange
  • OGEN Nasdaq
  • JZ Nasdaq
  • Market Cap
  • OGEN 1.2M
  • JZ 1.4M
  • IPO Year
  • OGEN N/A
  • JZ 2022
  • Fundamental
  • Price
  • OGEN $1.25
  • JZ $1.54
  • Analyst Decision
  • OGEN
  • JZ
  • Analyst Count
  • OGEN 0
  • JZ 0
  • Target Price
  • OGEN N/A
  • JZ N/A
  • AVG Volume (30 Days)
  • OGEN 329.1K
  • JZ 30.5K
  • Earning Date
  • OGEN 08-08-2025
  • JZ 09-26-2025
  • Dividend Yield
  • OGEN N/A
  • JZ N/A
  • EPS Growth
  • OGEN N/A
  • JZ N/A
  • EPS
  • OGEN N/A
  • JZ N/A
  • Revenue
  • OGEN N/A
  • JZ $34,090,704.00
  • Revenue This Year
  • OGEN N/A
  • JZ N/A
  • Revenue Next Year
  • OGEN N/A
  • JZ N/A
  • P/E Ratio
  • OGEN N/A
  • JZ N/A
  • Revenue Growth
  • OGEN N/A
  • JZ N/A
  • 52 Week Low
  • OGEN $1.23
  • JZ $1.39
  • 52 Week High
  • OGEN $75.60
  • JZ $14.60
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 27.96
  • JZ 30.68
  • Support Level
  • OGEN $1.35
  • JZ $1.57
  • Resistance Level
  • OGEN $1.49
  • JZ $1.79
  • Average True Range (ATR)
  • OGEN 0.09
  • JZ 0.09
  • MACD
  • OGEN 0.10
  • JZ 0.05
  • Stochastic Oscillator
  • OGEN 7.69
  • JZ 5.29

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: